Early Online
Open Access DOI:10.23937/2469-5696/1410098
Mercy Dein George, Stella U. Ken-Ezihuo and Evelyn M. Eze
Article Type: Original Research | First Published: March 03, 2025
Long-term storage of whole blood results in lesions, alterations in the biophysical, biochemical, and immunological characteristics of the cells. Each year, in Nigeria, about 1.5 million units of blood are used for blood transfusions as treatment intervention to a variety of medical conditions. This cross-sectional study evaluated changes in the levels of P-selectin, C-reactive protein and Hematological indices with respect to long-time storage of whole blood meant for transfusion in Port Harcou...
Article Formats
- Full Article
- XML
- EPub Reader
Open Access DOI:10.23937/2469-5696/1410097
Laith Alosoufe
Article Type: Research Article | First Published: 2024/11/01
Teenagers with thalassemia require knowledge about their condition in order to give adequate care, eliminate uncertainty, and create reasonable goals for themselves. The aim of the present study was to assess the knowledge and practices among adolescents with thalassemia at Rahma Governmental Hospital, Jordan, Irbid....
Article Formats
- Full Article
- XML
- EPub Reader
Open Access DOI:10.23937/2469-5696/1410096
Joanna Kae Ling Wong, Charlotte Chu-Hong Zheng, Samuel McGowan-Smyth and Chiraag Talati
Article Type: Original Article | First Published: 2024/06/06
Iron deficiency anaemia (IDA) has been observed concomitantly with unexplained leukopenia. However, this association is limited in literature. We investigated the association between IDA and leukopenia and explored iron therapy as a novel approach to improving immune function in patients with leukopenia....
Article Formats
- Full Article
- XML
- EPub Reader
Open Access DOI:10.23937/2469-5696/1410095
Dorothy P Kasubi, Clara C Chamba, Neema Budodi and Samira Mahfudh
Article Type: Original Article | First Published: 2024/02/16
Multiple myeloma is a potentially fatal hematological malignancy characterized by clonal growth of terminally differentiated B cells. The development of novel medicines (proteasome inhibitors, immunomodulatory medications, antibodies targeting cell surface molecules, and autologous stem cell transplantation) has improved patients' quality of life and overall survival rate with multiple myeloma. Despite the advancement of these new therapies that help resolve disease progression and hence provide...
Article Formats
- Full Article
- XML
- EPub Reader

Volume 11
Issue 1
Issue 1